BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30212680)

  • 1. Use of proton pump inhibitors and risk of ischemic events in the general population.
    Casula M; Scotti L; Galimberti F; Mozzanica F; Tragni E; Corrao G; Catapano AL
    Atherosclerosis; 2018 Oct; 277():123-129. PubMed ID: 30212680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
    Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
    Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
    Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
    J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
    Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
    Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.
    Wang KN; Bell JS; Tan ECK; Gilmartin-Thomas JFM; Dooley MJ; Ilomäki J
    Drugs Aging; 2019 Nov; 36(11):1027-1034. PubMed ID: 31485926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
    Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
    García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
    Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding.
    García Rodríguez LA; Johansson S; Cea Soriano L
    Thromb Haemost; 2013 Nov; 110(5):1014-24. PubMed ID: 23884111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
    Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
    Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
    Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
    J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study.
    Foresta A; Fernandez LO; Torrigiani G; Schena S; Roncaglioni MC; Nobili A; Tettamanti M; Franchi C; Fortino I; Succurro E; Sesti G; Baviera M
    Drugs Aging; 2024 Mar; 41(3):239-249. PubMed ID: 38367169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump Inhibitor Use and Myocardial Infarction: A Nested Case-Control Study in the UK Clinical Practice Research Datalink.
    Qian Y; Jick S
    Epidemiology; 2020 May; 31(3):423-431. PubMed ID: 31809341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.